 |
|
How myeloproliferative neoplasms patients’ experience and expectations differ from physicians’: the international MPN Landmark survey
Ja Min Byun, Soo-Mee Bang, Eun-Ji Choi, Ki-Seong Eom, Chul Won Jung, Hye-seon Kim, Jiwon Park, Chul Won Choi
Korean J Intern Med. 2022;37(2):444-454. Published online 2022 Feb 28 DOI: https://doi.org/10.3904/kjim.2021.475
|
|
Citations to this article as recorded by
 Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms
Jill Brennan-Cook, Lindsay Rein, Andrew Kuykendall, Natasha Johnson, Amie Koch, Allison O. Taylor, Christopher A. Jones, Thomas W. Leblanc
Journal of Palliative Medicine.2025; 28(2): 257. CrossRef Translation, Cultural Adaptation, and Validation into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form—Total Symptom Score (MPN-SAF TSS or MPN-10) Questionnaire
Mihnea-Alexandru Găman, Robyn Marie Scherber, Iulia Ursuleac, Ana Manuela Crişan, Sorina Nicoleta Bădeliţă, Bogdan Octavian Ionescu, Alexandra Elena Ghiaur, Melen Brînză, Nicoleta Pîrciulescu, Toma Octavian Lascăr, Camelia Cristina Diaconu, Amelia Maria G
Journal of Clinical Medicine.2024; 13(11): 3284. CrossRef The burden of symptoms and quality of life of filipino patients with myeloproliferative neoplasm: A multicenter cross‐sectional survey
Flordeluna Z. Mesina, Teresita E. Dumagay, Marissa M. Alejandria
Asia-Pacific Journal of Clinical Oncology.2024;[Epub] CrossRef A cross-sectional survey of symptoms and daily living among patients with polycythemia vera and their treating physicians in Japan
Yoko Edahiro, Keita Kirito, Akihiko Gotoh, Katsuto Takenaka, Yuka Sugimoto, Norio Komatsu, Kazuya Shimoda
Hematology.2023;[Epub] CrossRef Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms
Seug Yun Yoon, Sung-Yong Kim
The Korean Journal of Internal Medicine.2023; 38(6): 810. CrossRef
|